Method to achieve extended expression of DNA infused into liver
US11103582B2 · kind B2 · utility
0Cited by
10References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 5, 2018 |
| Grant date | Aug 31, 2021 |
| Priority date | — |
| Expiry date | Jul 9, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K48/0083
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Materials and methods for treating a patient to express a therapeutic agent comprising administering a Kupffer cell-suppressing substance in combination with a vehicle for introducing, into the patient, an exogenous nucleic acid comprising a sequence for expression of the agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.